OraSure Technologies Stock Crosses Above 200-Day Moving Average

The medical device company's stock price has risen above a key technical indicator.

Mar. 14, 2026 at 7:09am

Got story updates? Submit your updates here. ›

OraSure Technologies, Inc. (NASDAQ:OSUR), a Bethlehem, Pennsylvania-based diagnostic and medical device company, saw its stock price cross above its 200-day moving average on Friday. The stock traded as high as $3.15 before closing at $2.97, with a trading volume of 646,154 shares.

Why it matters

Crossing above the 200-day moving average is often seen as a bullish technical indicator, suggesting the stock may be entering a period of sustained upward momentum. However, the company has received a 'Reduce' rating from analysts, who cite concerns about its financial performance.

The details

OraSure Technologies develops and commercializes point-of-care and self-testing products, including its flagship OraQuick rapid HIV test. The company's stock has a 50-day simple moving average of $2.81 and a 200-day simple moving average of $2.80, with a market capitalization of $205.32 million, a price-to-earnings ratio of -3.19, and a beta of 0.88.

  • OraSure Technologies' stock crossed above its 200-day moving average on Friday, March 14, 2026.
  • The company's 50-day simple moving average is $2.81.

The players

OraSure Technologies, Inc.

A Bethlehem, Pennsylvania-based diagnostic and medical device company specializing in the development, manufacture, and commercialization of point-of-care and self-testing products, including its flagship OraQuick rapid HIV test.

Got photos? Submit your photos here. ›

What they’re saying

“We must not let individuals continue to damage private property in San Francisco.”

— Robert Jenkins, San Francisco resident

The takeaway

The crossing of OraSure Technologies' stock price above its 200-day moving average is a potentially positive technical signal, but the company's overall financial performance and analyst ratings suggest caution is warranted for investors.